Impact Factor

2.6

Global Health & Medicine -> 2021 Vol.3(No.1)

Editorial
COVID-19 vaccines: implementation, limitations and opportunities
Global Health & Medicine. 2021; 3(1):1-5.
Policy Forum
Business models for sustainable development: Projects of global extension of medical technologies of Japan
Global Health & Medicine. 2021; 3(1):6-10.
For further collaboration on strengthening Universal Health Coverage (UHC): Partnership project between Japan and Thailand
Global Health & Medicine. 2021; 3(1):11-14.
Review
Secondary dyslipidemia: its treatments and association with atherosclerosis
Global Health & Medicine. 2021; 3(1):15-23.
Current state and prospect of the perioperative strategy for nonsmall cell lung cancer
Global Health & Medicine. 2021; 3(1):24-30.
Current status of doublet combinations of platinum and fluoropyrimidines using oxaliplatin for advanced gastric cancer
Global Health & Medicine. 2021; 3(1):31-36.
Original Article
Investigation of users' experiences for online access to their electronic health records in Japan
Global Health & Medicine. 2021; 3(1):37-43.
Communication
What is the current status of Japan's efforts to meet global goals and targets to eliminate cervical cancer?
Global Health & Medicine. 2021; 3(1):44-47.
Enhancing the blood safety program in Myanmar: Report on projects of global extension of medical technologies of Japan
Global Health & Medicine. 2021; 3(1):48-51.
Enhancing the use of computed tomography and cardiac catheterization angiography in Zambia: A project report on a global extension of medical technology in Japan
Global Health & Medicine. 2021; 3(1):52-55.